Director, GI/Liver Biomarkers & Translational Research
Core
Own end-to-end biomarker and translational strategy for inflammatory bowel disease (IBD) and liver programs, integrating tissue, clinical, and multi-omic evidence to drive clinical development and regulatory decisions.
Role type
Senior IC scientific leader (Director)
Builds
Clinical-stage assets for IBD and liver diseases
Domain
Biopharma / Gastroenterology & Hepatology / Translational Medicine
Required skills
Biomarker strategy, translational medicine, human immunology, GI/IBD expertise, liver inflammation/fibrosis knowledge, clinical trial leadership, regulatory interactions, cross-functional leadership, resource management, scientific communication, team development
Preferred skills
Crohn's disease/ulcerative colitis leadership, liver histopathology, FDA/EMA interaction experience, multi-omics data integration, companion diagnostic strategy, KOL/consortia relationships
Technologies
Single-cell sequencing, spatial transcriptomics, proteomics, genomics, imaging, histopathology
Responsibilities
Define decision criteria for target engagement, dose, and patient selection; lead complex programs from early development through Phase II/III; oversee assay and vendor strategy; establish collaborations with investigators and KOLs; lead publication and evidence-dissemination strategy; develop direct reports and elevate scientific standards.
Seniority
Director, hands-on IC with strategic oversight